Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126248161 | 12624816 | 1 | I | 20160802 | 0 | 20160804 | 20160804 | DIR | 58.00 | YR | M | N | 160.00000 | LBS | 20160803 | N | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126248161 | 12624816 | 1 | PS | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | D | 20171031 | 0 | 1 | DF | COATED TABLET | HS | |||||
| 126248161 | 12624816 | 2 | C | FINASTERIDE. | FINASTERIDE | 1 | 0 | ||||||||||||
| 126248161 | 12624816 | 3 | C | ATORVASTATIN | ATORVASTATIN | 1 | 0 | ||||||||||||
| 126248161 | 12624816 | 4 | C | FLUTICASONE PROPIONATE. | FLUTICASONE PROPIONATE | 1 | 0 | ||||||||||||
| 126248161 | 12624816 | 5 | C | ROGAINE SPRAY | 2 | 0 | |||||||||||||
| 126248161 | 12624816 | 6 | C | MULTIVITAMINS | VITAMINS | 1 | 0 | ||||||||||||
| 126248161 | 12624816 | 7 | C | MAGNESIUM | MAGNESIUM | 1 | 0 | ||||||||||||
| 126248161 | 12624816 | 8 | C | POTASSIUM | POTASSIUM | 1 | 0 | ||||||||||||
| 126248161 | 12624816 | 9 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | 0 | ||||||||||||
| 126248161 | 12624816 | 10 | C | BABY ASPIRIN | ASPIRIN | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126248161 | 12624816 | 1 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126248161 | 12624816 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126248161 | 12624816 | Dermatitis | |
| 126248161 | 12624816 | Dysgeusia | |
| 126248161 | 12624816 | Lacrimation increased | |
| 126248161 | 12624816 | Muscle fatigue | |
| 126248161 | 12624816 | Peripheral swelling | |
| 126248161 | 12624816 | Pruritus | |
| 126248161 | 12624816 | Stomatitis | |
| 126248161 | 12624816 | Thyroid disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126248161 | 12624816 | 1 | 20160627 | 20160803 | 0 |